tirzepatide surmount 1 SURMOUNT-1: Adults achieve weight loss of 16% or more at 72 weeks with Tirzepatide after intensive lifestyle intervention

Modulacin de ciertos sntomas psiquitricos , lo que abre nuevas lneas de investigacin en salud mental asociada a trastornos metablicos

J Cell Physiol, 2012

Presented for research literature review only McCartney M (2023)

It directly replaces or supplements the bodys natural insulin, enabling glucose to enter cells and be used for energy

However, some people report: Different timing of fullness signals Slightly faster gastric emptying (glucagon effect) Less bloating compared to tirzepatide If you had significant GI issues on tirzepatide, retatrutide is often better tolerated once you're past the first week

13.2%), nausea (13.7%, 20.8%, 28.0% vs